1
Clinical Trials associated with Autologous adipose derived stem cells(Centre Hospitalier Universitaire de Montpellier)A Phase I, Prospective, Bi-centric,Single -Arm, Open-label, Dose-escalating Clinical Trial to Evaluate the Safety of a Single Injection of Autologous Adipose Derived Mesenchymal Stromal Cells in the Treatment of Severe Osteoarthritis of the Knee Joint
Primary:
To study the safety of a single injection of autologous adipose derived mesenchymal stromal cells (ASCs) on patients with moderate or severe osteoarthritis of the knee (OA).
Secondary:
To study the efficacy of a single injection of autologous adipose derived mesenchymal stromal cells on patients with moderate or severe osteoarthritis of the knee (OA).
100 Clinical Results associated with Autologous adipose derived stem cells(Centre Hospitalier Universitaire de Montpellier)
100 Translational Medicine associated with Autologous adipose derived stem cells(Centre Hospitalier Universitaire de Montpellier)
100 Patents (Medical) associated with Autologous adipose derived stem cells(Centre Hospitalier Universitaire de Montpellier)
100 Deals associated with Autologous adipose derived stem cells(Centre Hospitalier Universitaire de Montpellier)